📈 Jumpstart Signal Watchlist — September 11, 2026

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 Current $13.01 is 8% below 3yr high $14.14 · ⏳ SMA200 $6.75 (current price $13.01 is above) · 💰 Market Cap $734M
- PAYS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 450% (>20%); Revenue growth 48% (>15%); ROE 26% (>15%); Low LT D/E 0.06 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (14.8%)
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×2; showing 4 of 5).
✅ Paysign (NASDAQ:PAYS) Stock Gets Fair Value Boost After Q2 And Guidance ... — Yahoo Finance.
🤖 The article says Barrington raised its price target on Paysign in August after the company’s Q2 results and guidance, which is supportive for the stock. It reflects improving analyst sentiment tied to actual operating performance and outlook.
✅ Paysign (NASDAQ:PAYS) Hits New 12-Month High - What's Next? — MarketBeat.
🤖 The piece highlights Paysign’s new 52-week high and notes the company’s fiscal 2026 EPS guidance of $0.35–$0.37. Strong price action combined with guidance is favorable for the stock.
⚪️ Paysign (NASDAQ:PAYS) CFO Sells $441700.00 in Stock — MarketBeat.
🤖 This is an insider sale disclosure, which is backward-looking regulatory information rather than a business catalyst. It does not by itself imply a directional change in the company’s fundamentals or outlook.
⚪️ Paysign (NASDAQ:PAYS) Stock Rating Lowered by Wall Street Zen — MarketBeat.
🤖 The article reports a small analyst downgrade from strong-buy to buy, but the broader consensus remains positive and the change is mild. On balance, this is not a strong catalyst either way.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: Vir Biotechnology is a clinical-stage biopharmaceutical company that develops medicines for serious infectious diseases and cancer. Its work centers on immune-based therapies, including antibody-based and other platform-driven drug candidates such as programs for hepatitis delta, hepatitis B, and solid tumors.
- 🎯 Current $10.62 is 18% below 3yr high $12.90 · ⏳ SMA200 $8.61 (current price $10.62 is above) · 💰 Market Cap $1.8B
- VIR shows decent technicals supported by positive sentiment.

💎 Quality (Q): 32/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 159% (>20%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 54 in healthy mid-range
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Brokerages — MarketBeat.
🤖 Eight analysts maintained a consensus Moderate Buy rating, with an average 12-month price target of $21.57 versus a recent share price of $11.39. The article also cited Vir's substantial quarterly EPS and revenue beats.
✅ Vir Biotechnology stock hits 52-week high at 11.66 USD — Investing.com.
🤖 Vir shares reached a 52-week high after the company reported strong second-quarter results, including $80.1 million in net income and approximately $1.01 billion in cash, cash equivalents, and investments. H.C. Wainwright also reiterated its Buy rating and $20 price target, citing progress in hepatitis D programs.
✅ Vir Biotechnology (NASDAQ:VIR) Sets New 52-Week High — MarketBeat.
🤖 The stock reached a new 52-week high after Vir beat quarterly expectations, reporting adjusted EPS of $0.47 versus $0.33 expected and revenue of $238.95 million versus $135.88 million forecast. Analyst sentiment remained broadly favorable with a Moderate Buy consensus.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Hewlett Packard Enterprise (HPE) is an enterprise technology company that provides compute, storage, networking, and software solutions designed for hybrid IT environments and AI infrastructure.
- 🎯 At/above 3yr high $62.09 (current $62.09) · ⏳ SMA200 $33.74 (current price $62.09 is above) · 💰 Market Cap $82.5B
- HPE shows decent technicals supported by positive sentiment.

💎 Quality (Q): 49/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 405% (>20%); Revenue growth 34% (>15%); Low LT D/E 0.82 (<1.0); PEG ratio 0.08 (<1.5).
⏰ Entry (E): 7/20
- 🔔 Strong above EMA21 (13.8%)
- 🔔 Strong above EMA50 (21.1%)
- 📈 RSI at 64 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (mixed coverage; ✅×4 ❌×1; showing 3 of 5).
✅ Hewlett Packard (HPE) Reported $12.2B of Revenue and $1.0B of ... — Yahoo Finance.
🤖 The article reports HPE expects at least $3.75 billion in fiscal 2026 free cash flow and at least $5.0 billion in fiscal 2027, following strong reported results. The increased cash-flow outlook is supportive of the company’s financial trajectory.
✅ Hewlett Packard Enterprise (HPE)’s AI Boom Fuels Growth, Margins, and Healthier Outlook — Yahoo Finance.
🤖 HPE reported fiscal Q3 revenue of $12.2 billion, up 34% year over year, with substantial growth in cloud and AI, servers, and networking. It also raised its fiscal 2026 revenue-growth outlook to 34%-37%.
❌ Wells Fargo & Company Lowers Hewlett Packard Enterprise (NYSE:HPE) Price Target to $54.00 — MarketBeat.
🤖 Wells Fargo reduced its HPE price target from $67 to $54 while maintaining an Equal Weight rating. Although the report also noted HPE’s earnings beat and raised guidance, the analyst target reduction is a negative valuation signal.
🍭 Bonus (B): 10/10 — Computer & Office Equipment (Technology sector)

🏢 What they do: Avnet, Inc. is a global distributor of electronic components and a technology solutions provider that supports engineers, entrepreneurs, and startups in taking tech projects from idea and design to prototype and mass production.
- 🎯 At/above 3yr high $99.63 (current $99.63) · ⏳ SMA200 $72.09 (current price $99.63 is above) · 💰 Market Cap $8.2B
- AVT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (12.5% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1578% (>20%); Revenue growth 48% (>15%); Low LT D/E 0.39 (<1.0).
⏰ Entry (E): 5/20
- 🔔 Strong above EMA21 (8.5%)
- 🔔 Strong above EMA50 (10.7%)
- 📈 RSI at 67 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ Why Is Avnet (AVT) Down 6.2% Since Last Earnings Report? — Yahoo Finance.
🤖 Avnet's fiscal fourth-quarter adjusted EPS of $2.28 exceeded the $1.76 consensus estimate by 29.55%. Although the share-price performance discussed was weaker after earnings, the reported earnings beat is fundamentally positive.
✅ Avnet (AVT) Lifts Dividend After Buybacks And Growth While Fair ... — Yahoo Finance.
🤖 Avnet approved a 5.7% increase in its quarterly cash dividend to $0.37 per share. The higher shareholder payout is a positive capital-return signal.
✅ AVT Jumps 37.8% in 6 Months: Should You Buy, Sell or Hold the ... — Yahoo Finance.
🤖 The article highlights Avnet's record fiscal fourth-quarter sales of $8.3 billion, up 48% year over year and 17% sequentially. This operating momentum is positive for the stock.
🍭 Bonus (B): 0/10 — Electronic Parts - Wholesale

🏢 What they do: ScanSource is a technology distributor that connects hardware, software, connectivity, and cloud solutions to channel partners and businesses. Its products and services include point-of-sale systems, barcode and data-capture equipment, networking, communications, physical security, payments, and related value-added services.
- 🎯 Current $58.19 is 1% below 3yr high $58.89 · ⏳ SMA200 $44.41 (current price $58.19 is above) · 💰 Market Cap $1.2B
- SCSC shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (12.7% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 40% (>20%); Revenue growth 17% (>15%); Low LT D/E 0.38 (<1.0).
⏰ Entry (E): 2/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ ScanSource Completes Acquisition of MicroAge — Yahoo Finance.
🤖 ScanSource completed its acquisition of MicroAge, expanding its technology-distribution capabilities in areas including cloud, cybersecurity and managed services. The completed transaction is a company-specific strategic expansion catalyst.
✅ ScanSource (SCSC) Just Posted Record Earnings And A ... — Yahoo Finance.
🤖 The article highlights ScanSource’s record non-GAAP profit, 17.3% year-over-year sales growth to $953.1 million, and 43.1% growth in non-GAAP diluted EPS to $1.46. It also discusses the MicroAge acquisition, reinforcing the favorable operating and strategic developments.
✅ ScanSource (NASDAQ:SCSC) Upgraded at Zacks Research — MarketBeat.
🤖 Zacks Research upgraded ScanSource from Hold to Strong Buy. The report also notes quarterly EPS of $1.46 exceeded the $1.14 consensus estimate and revenue rose 17.3% year over year.
🍭 Bonus (B): 0/10 — Computers & Software - Wholesale

🏢 What they do: Zeta Global is an AI-powered marketing technology company that provides enterprises with a unified platform combining identity data, artificial intelligence, and multichannel marketing tools to acquire, grow, and retain customers.
- 🎯 Current $30.18 is 18% below 3yr high $36.74 · ⏳ SMA200 $20.29 (current price $30.18 is above) · 💰 Market Cap $7.3B
- ZETA shows decent technicals supported by positive sentiment.

💎 Quality (Q): 35/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 150% (>20%); Revenue growth 44% (>15%); Low LT D/E 0.21 (<1.0).
⏰ Entry (E): 5/20
- 🔔 Strong above EMA50 (13.6%)
- 🔔 VWMA trending up (5 consecutive days)
- ⚠️ RSI reversing from overbought (57) — BEARISH
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ Zeta Global stock hits 52-week high at $29.95 — Investing.com.
🤖 The article says Zeta Global hit a new 52-week high, reflecting strong recent price momentum. It also cites revenue that beat estimates and a raised full-year outlook, which are supportive for the stock.
✅ Zeta Global (NYSE:ZETA) Hits New 12-Month High — MarketBeat.
🤖 This piece highlights Zeta Global reaching a new 52-week high and notes a broadly positive analyst backdrop. It also references strong revenue growth and multiple raised price targets, which are favorable for the shares.
⚪️ Why Is Zeta (ZETA) Up 12.5% Since Last Earnings Report? — Zacks.
🤖 This is a performance-review article rather than a fresh catalyst, and it mainly discusses the stock's move since the last earnings report. It does not appear to contain a new company-specific development that would strongly change the stock’s outlook.
🍭 Bonus (B): 10/10 — Prepackaged Software (Technology sector)

🏢 What they do: Quanex Building Products Corporation is a manufacturer of components and materials used in the building products industry, especially for windows, doors, and cabinets. Its products include fenestration components, insulating glass spacers, vinyl profiles, window and door screens, hardware, and cabinet components.
- 🎯 Current $21.57 is 44% below 3yr high $38.79 · ⏳ SMA200 $18.24 (current price $21.57 is above) · 💰 Market Cap $988M
- NX shows decent technicals supported by positive sentiment.

💎 Quality (Q): 45/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 110% (>20%); Low LT D/E 0.19 (<1.0); PEG ratio 0.19 (<1.5).
⏰ Entry (E): 5/20
- 🔔 Strong above EMA21 (5.5%)
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ Quanex Building Products (NYSE:NX) Sets New 52-Week High — MarketBeat.
🤖 Quanex reported third-quarter adjusted EPS of $0.79 and revenue of $501.8 million, beating analyst expectations. Shares rose 20.7% to a new 52-week high, although the consensus analyst rating remained Hold.
✅ Sidoti Has Positive Outlook of NX FY2026 Earnings — MarketBeat.
🤖 Sidoti raised its FY2026 EPS estimate for Quanex to $1.77 from $1.66 after the company exceeded quarterly earnings expectations. The estimate increase is a favorable analyst revision for NX.
⚪️ Quanex declares $0.08 quarterly dividend payable Sept. 30 — Investing.com.
🤖 Quanex declared a quarterly cash dividend of $0.08 per share. The dividend provides a modest shareholder return but, without a change in the payout or other catalyst, is broadly neutral for the stock price.
🍭 Bonus (B): 0/10 — Rolling & Drawing - Nonferrous